Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?

Christopher W MangieriCristian D ValenzuelaIan B SolskyRichard A EraliKonstantinos I VotanopoulosPerry ShenEdward A Levine

Published in: Annals of surgical oncology (2022)

This analysis found no discernable association with NAT oxaliplatin exposure in regard to survival outcomes following CRS/HIPEC stratified out by perfusion agent.

Keyphrases

locally advanced
rectal cancer
contrast enhanced
squamous cell carcinoma
radiation therapy
lymph node
magnetic resonance imaging
chemotherapy induced
magnetic resonance
free survival